1,2-Dichloroethane → HCID 86637025, compound
Reaction equation
Cl.Cl.Cl.[NH2:4][C:5]1[S:6][CH:7]=[C:8]([CH2:10][N:11]([CH3:22])[C:12]2[NH:17][C:16]([Cl:18])=[N:15][C:14](=[N:19][NH2:20])[C:13]=2[F:21])[N:9]=1.[CH:23]1([CH2:28][C@H:29]([CH2:33][N:34]([CH:42]=[O:43])[O:35][CH:36]2[CH2:41][CH2:40][CH2:39][CH2:38][O:37]2)[C:30](O)=[O:31])[CH2:27][CH2:26][CH2:25][CH2:24]1.C1C=NC2N(O)N=NC=2C=1.CN1CCOCC1.C(Cl)CCl>CN(C=O)C>[NH2:4][C:5]1[S:6][CH:7]=[C:8]([CH2:10][N:11]([CH3:22])[C:12]2[N:17]=[C:16]([Cl:18])[N:15]=[C:14]([NH:19][NH:20][C:30](=[O:31])[C@H:29]([CH2:28][CH:23]3[CH2:24][CH2:25][CH2:26][CH2:27]3)[CH2:33][N:34]([O:35][CH:36]3[CH2:41][CH2:40][CH2:39][CH2:38][O:37]3)[CH:42]=[O:43])[C:13]=2[F:21])[N:9]=1Participants
7
Reactant 5
Product 1
Reagents, catalysts & solvents 1
Procedure
6-[[(2-Amino-1,3-thiazol-4-yl)methyl](methyl)amino]-2-chloro-5-fluoro-4(1H)-pyrimidinone hydrazone trihydrochloride (150 mg, 0.29 mmol), (2R)-3-cyclopentyl-2-{[formyl(tetrahydro-2H-pyran-2-yloxy)amino]methyl}propanoic acid (120 mg, 0.4 mmol), and HOAt (59 mg, 0.43 mmol) were dissolved in 10 mL of DMF. NMM (0.2 mL, 1.8 mmol) was added, followed by EDC (85 mg, 0.43 mmol). After stirring overnight at room temperature, the reaction mixture was purified by RP-HPLC [(2R)-3-(2-{6-[[(2-amino-1,3-thiazol-4-yl)methyl](methyl)amino]-2-chloro-5-fluoro-4-pyrimidinyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide (110 mg, 52%). LCMS: (M+H)+: 585.2.
Workup
- customthe reaction mixture was purified by RP-HPLC [(2R)-3-(2-{6-[[(2-amino-1,3-thiazol-4-yl)methyl](methyl)amino]-2-chloro-5-fluoro-4-pyrimidinyl}hydrazino)-2-(cyclopentylmethyl)-3-oxopropyl](tetrahydro-2H-pyran-2-yloxy)formamide (110 mg, 52%)
Sources & evidence
- ORD record
- ord-a9a8d5a0067f4a7eb2f5cfc7d2014952
- Source dataset
- uspto-grants-2011_02
- Patent number
- US07893056B2
Reaction notes
Loading…